Anzeige
Mehr »
Login
Montag, 06.05.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
+56,25% in 5 Tagen: Genialer Schachzug - diese Übernahme verändert alles
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
65 Leser
Artikel bewerten:
(0)

Brazil IVD Market Report 2017

DUBLIN, July 10, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Brazil IVD Market Analysis" report to their offering.

Logo

The Brazilian in vitro diagnostic (IVD) market is ripe for entry. The country has a growing middle class, stabilizing economy, increasing urban population, and a supportive government. The county is witnessing a major shift toward the private health industry, which supports growth of IVD technologies that are expensive or not typically covered at the public level. An increasing interest in molecular testing technologies, prenatal screening, and point-of-care (POC) glucose testing are driving market growth.

Brazil IVD Market Analysis is designed to provide the reader with an overview of the Brazilian laboratory market and its influences.

The focus is on the IVD discipline including reagents, consumables, calibrators and controls of the following sub-segments:

- Clinical Chemistry

- Immunoassays

- Microbiology and Molecular Testing

- Point-of-Care Testing

Increasing incidence of non-communicable disease, a steady incidence of infectious diseases, an increasing disease risk with current lifestyle trends (higher obesity rate, lower activity rates), and other factors have contributed to the current and future Brazil IVD market outlook as outlined in the report:



- Brazil IVD Sales by Market Segment, 2016-2021 (Clinical Chemistry, Immunoassay, Microbiology/Molecular, POC, Histology, Other, Total)


- Brazil IVD Sales by Market Segment, 2016 Market Distribution (%) (Clinical Chemistry, Immunoassays, Microbiology/Molecular, POC, Histology, Other)


- Brazil - Clinical Chemistry Market, 2016-2021


- Brazil - Immunoassay Market Distribution, 2016-2021 (%) (Infectious Disease, Other, Total Immunoassay)


- Brazil - Immunoassay Market Value by Segment, 2016 vs. 2021 (Infectious Disease, Other)


- Brazil - Microbiology/Molecular Testing Market Distribution, 2016-2021 (%) (Infectious Disease, Other, Total Microbiology/Molecular Testing)


- Brazil Microbiology/Molecular Testing Market Value by Segment, 2016 vs. 2021 (Infectious Disease, Other)


- POC Market Distribution, 2016-2021 (%) (POC Glucose, POC Infectious Disease, POC Other, Total POC)


- Brazil POC Market Value by Segment, 2016 vs. 2021 (POC Glucose, POC Infectious Disease, Others)


- Brazil - Histology Market, 2016-2021

Key Topics Covered:





1: Executive Summary



2: Brazil Overview



3: The Health System In Brazil



4: IVD Markets In Brazil



5: Competitive Analysis And Profiles



- Abbott Laboratories


- Alere


- Becton, Dickinson And Company


- Biomérieux SA


- Danaher Corporation


- Roche (F. Hoffman-La Roche, Ltd.)


- Siemens Healthineers


- Sysmex Corporation



For more information about this report visit

https://www.researchandmarkets.com/research/f8x5sl/brazil_ivd_market

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Kupfer - Jetzt! So gelingt der Einstieg in den Rohstoff-Trend!
In diesem kostenfreien Report schaut sich Carsten Stork den Kupfer-Trend im Detail an und gibt konkrete Produkte zum Einstieg an die Hand.
Hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.